Trial Profile
Phase 2b clinical trial of VK0612 in patients with poorly-controlled type 2 diabetes
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2015
Price :
$35
*
At a glance
- Drugs VK 0612 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Viking Therapeutics
- 17 Feb 2015 New trial record